Chemotherapy in Treating Patients With Non-Small Cell Lung Cancer
Status:
Completed
Trial end date:
2010-07-01
Target enrollment:
Participant gender:
Summary
The purpose of this study is to compare the combination of pemetrexed and carboplatin with
the combination of docetaxel and carboplatin in terms of survival without Grade 3 or 4
toxicity in previously untreated patients with locally advanced or metastatic non-small cell
lung cancer (NSCLC).